Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 15;11(3):147.
doi: 10.21037/atm-22-6637.

The oncogenic and immunological roles of histidine triad nucleotide-binding protein 1 in human cancers and their experimental validation in the MCF-7 cell line

Affiliations

The oncogenic and immunological roles of histidine triad nucleotide-binding protein 1 in human cancers and their experimental validation in the MCF-7 cell line

Xuzhen Wang et al. Ann Transl Med. .

Abstract

Background: Histidine triad nucleotide binding protein 1 (HINT1) is a haplo-insufficient tumor suppressor gene that plays a significant role in cell proliferation and survival. However, to date, no systematic pan-cancer analysis has been conducted to explore its function in prognosis, and its oncogenic and immunological roles. We also analyzed the role of HINT1 in breast cancer (BC) progression in vitro.

Methods: An analysis of the HINT1 expression pattern was performed using the TIMER database. The infiltration of immune cells into several cancer types was also studied using the Xena Shiny tool. To determine the relationship between stemness and the expression of HINT1 mRNA, the Spearman correlation test was used with the SangerBox tool. The correlation between HINT1 and functional states in various cancers was determined from the CancerSEA database. The potential role of HINT1 in BC oncogenesis was also investigated by Western blot and Annexin V/PI assays.

Results: The Cancer Genome Atlas pan-cancer data analysis suggested that HINT1 was extensively altered in most tumor tissues but not in most adjacent normal tissues. A high expression of HINT1 was associated with the decreased infiltration of cluster of differentiation (CD)4+ T cells. Importantly, increased HINT1 expression was also associated with a large majority of tumors with high stemness and lower stromal, immune, and estimate scores. Further, the expression of HINT1 was significantly associated with the tumor mutational burden (TMB) and microsatellite instability (MSI) in certain tumor types. Finally, HINT1 overexpression was found to impair BC progression by promoting cell apoptosis. HINT1 upregulation also reduced the expression of microphthalmia transcription factor (MITF) and β-catenin in BC Michigan Cancer Foundation-7 (MCF-7) cells, and the phosphorylation of protein kinase B (p-Akt).

Conclusions: The present study showed that HINT1 plays an oncogenic role in various cancers and could also be used as a biomarker for BC.

Keywords: Histidine triad nucleotide binding protein 1 (HINT1); apoptosis; breast cancer (BC); oncogenic role; tumor microenvironment.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://atm.amegroups.com/article/view/10.21037/atm-22-6637/coif). The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
The expression of HINT1 extensively changed in pan-cancers. *, P<0.05, **, P<0.01, ***, P<0.001.
Figure 2
Figure 2
The correlation between the mRNA expression of HINT1 and tumor infiltration, and the relationship between tumor stemness and the expression of HINT1 mRNA. (A) The correlation between the mRNA expression of HINT1 in 6 immune cell types and tumor infiltration in 32 TCGA tumor samples. (B) The relationship between DNAss and the expression of HINT1 mRNA. (C) The relationship between RNAss and the expression of HINT1 mRNA.
Figure 3
Figure 3
The correlation between the HINT1 mRNA expression and stemness, TMB, and MSI in 32 TCGA tumors. (A) Stemness. (B) TMB. (C) MSI. *, P<0.05, **, P<0.01. TMB, tumor mutational burden; MSI, microsatellite instability; TCGA, The Cancer Genome Atlas.
Figure 4
Figure 4
Association between HINT1 gene expression and stromal scores in 33 different cancer types.
Figure 5
Figure 5
Association between HINT1 gene expression and immune scores in 33 different cancer types.
Figure 6
Figure 6
Association between HINT1 gene expression and estimate scores in 33 different cancer types.
Figure 7
Figure 7
Oncogenic role of HINT1 in breast cancer cells. (A) Expression pattern of HINT1 in single-cell and its relationship with tumor functional status. (B,C) The effect of HINT1 on apoptosis in MCF-7 cells. (D-H) The protein expression levels of MITF, β-catenin, p-Akt, and Akt were measured by western blotting. *, P<0.05, ***, P<0.001. GAPDH was used as the loading control. MCF-7, Michigan Cancer Foundation-7; MITF, microphthalmia transcription factor; p-Akt, phosphorylation of protein kinase B; GAPDH, glyceraldehyde 3-phosphate dehydrogenase.

Similar articles

Cited by

References

    1. Wang L, Li H, Zhang Y, et al. HINT1 inhibits beta-catenin/TCF4, USF2 and NFkappaB activity in human hepatoma cells. Int J Cancer 2009;124:1526-34. 10.1002/ijc.24072 - DOI - PMC - PubMed
    1. Wang L, Zhang Y, Li H, et al. Hint1 inhibits growth and activator protein-1 activity in human colon cancer cells. Cancer Res 2007;67:4700-8. 10.1158/0008-5472.CAN-06-4645 - DOI - PubMed
    1. Saldivar JC, Park D. Mechanisms shaping the mutational landscape of the FRA3B/FHIT-deficient cancer genome. Genes Chromosomes Cancer 2019;58:317-23. 10.1002/gcc.22684 - DOI - PubMed
    1. Waters CE, Saldivar JC, Hosseini SA, et al. The FHIT gene product: tumor suppressor and genome "caretaker". Cell Mol Life Sci 2014;71:4577-87. 10.1007/s00018-014-1722-0 - DOI - PMC - PubMed
    1. Su T, Suzui M, Wang L, et al. Deletion of histidine triad nucleotide-binding protein 1/PKC-interacting protein in mice enhances cell growth and carcinogenesis. Proc Natl Acad Sci U S A 2003;100:7824-9. 10.1073/pnas.1332160100 - DOI - PMC - PubMed